Kenneth Sands is a corporate associate at Latham & Watkins.

Mr. Sands advises public and private issuers, investment banks, and private equity clients primarily on corporate and securities matters in a range of global capital markets transactions.

Mr. Sands’ experience also includes advising corporate clients on public company reporting and other corporate transactions.

He is active in the firm’s pro bono practice, primarily working on guardian ad litem cases. Mr. Sands is also a member of the firm’s Recruiting Committee and previously served on the firm’s Training & Career Enhancement Committee.

Mr. Sands joined the firm in 2017 after graduating from Northwestern Pritzker School of Law. While in law school, Mr. Sands advised startups and entrepreneurs through the Bluhm Legal Clinic’s Donald Pritzker Entrepreneurship Law Center.

Prior to law school, Mr. Sands worked for more than two years as an analyst in the investment management division of a major investment bank. Mr. Sands also worked for almost two years as an analyst for an institutional investment consulting firm.

Mr. Sands has recently advised:

Capital Markets

  • Colfax Corporation (now Enovis Corporation) in the spin-off and listing of its fabrication technology business, ESAB Corporation, on the New York Stock Exchange
  • Tritium DCFC Limited in connection with its deSPAC merger with Decarbonization Plus Acquisition Corporation II and its subsequent listing on the Nasdaq Stock Market
  • The underwriters in connection with Thorne HealthTech, Inc.’s IPO
  • Ventas, Inc. in a public offering of US$794 million of common stock
  • Colfax Corporation in a public offering of US$741 million of common stock
  • Harmony Biosciences Holdings, Inc. in its US$147.6 million IPO
  • The underwriters in public offerings of common stock by Essential Properties Realty Trust, Inc., Assembly Biosciences, Inc., Aptevo Therapeutics Inc., Construction Partners, Inc., and Actinium Pharmaceuticals, Inc.
  • The sales or placement agents in connection with at-the-market offerings of common stock by Douglas Emmett, Inc., Essential Properties Realty Trust, Inc., Aptevo Therapeutics Inc., Pfenex Inc., Endologix, Inc., and Alpine Immune Sciences, Inc.
  • Hyatt Hotels Corporation in a public offering of US$900 million of 5.375% five-year and 5.750% 10-year unsecured senior notes
  • Ventas, Inc. in multiple SEC-registered bond offerings and debt tender offers
  • Infraestructura Energética Nova, S.A.B. de C.V. (IEnova) in connection with its global offering of US$800 million in 4.750% senior notes due 2051
  • The initial purchasers in connection with multiple high-yield notes offerings by Viking Cruises
  • The initial purchasers in connection with a high-yield notes offering by Cameron LNG, LLC
  • Cheniere Energy Partners in connection with multiple senior notes offerings
  • Sabine Pass Liquefaction, LLC in connection with multiple senior notes offerings

Public Company Representation

  • Tritium DCFC Limited
  • Harmony Biosciences Holdings, Inc.
  • Ventas, Inc.
  • Highlands REIT, Inc.
  • InvenTrust Properties Corp.

Bar Qualification

  • Illinois


  • JD, Northwestern University Pritzker School of Law, 2017
    cum laude
  • BS in Management, Purdue University, 2012